4/A//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4/A
Accession 0001179110-15-001634
CIK 0001436304operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:12 PM ET
Size
6.2 KB
Accession
0001179110-15-001634
Insider Transaction Report
Form 4/AAmended
Rich Douglas A.
Vice President Operations
Transactions
- Award
Stock Option (right to buy)
2015-01-29+28,217→ 28,217 totalExercise: $38.53Exp: 2025-01-29→ Common Stock (28,217 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2015 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to continued employment through each such vesting date.
- [F2]The purpose of this amendment is to correctly report the title of the derivative security in Table II, Box 1. Except as otherwise noted in this Form 4/A, all other information disclosed in the reporting person's original Form 4 filed with the Securities and Exchange Commission on February 2, 2015 was accurately reported.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:12 PM ET
- Size
- 6.2 KB